Atezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?

Journal article

Open access

Chelsea E. Stewart and Dana M. Chase

Gynecology and Pelvic Medicine

01/2023

Files and links (1)

url

https://doi.org/10.21037/gpm-24-9View

Published (Version of record) Open

1 Record Views

Title: Atezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?
Creators: Chelsea E. Stewart
Dana M. Chase
Publication Details: Gynecology and Pelvic Medicine
Identifiers: 991006108146102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article